A detailed history of California Public Employees Retirement System transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 22,295 shares of MDGL stock, worth $6.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,295
Previous 22,262 0.15%
Holding current value
$6.93 Million
Previous $6.24 Million 24.13%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$212.22 - $292.96 $7,003 - $9,667
33 Added 0.15%
22,295 $4.73 Million
Q2 2024

Aug 14, 2024

BUY
$193.33 - $291.99 $400,579 - $605,003
2,072 Added 10.26%
22,262 $6.24 Million
Q4 2023

Feb 01, 2024

SELL
$120.4 - $237.13 $562,027 - $1.11 Million
-4,668 Reduced 18.78%
20,190 $4.67 Million
Q3 2023

Nov 02, 2023

BUY
$146.04 - $225.78 $762,474 - $1.18 Million
5,221 Added 26.59%
24,858 $3.63 Million
Q2 2023

Aug 09, 2023

BUY
$203.88 - $312.0 $1.37 Million - $2.09 Million
6,699 Added 51.78%
19,637 $4.54 Million
Q1 2023

May 12, 2023

BUY
$231.06 - $307.08 $2.99 Million - $3.97 Million
12,938 New
12,938 $3.13 Million
Q2 2021

Aug 13, 2021

SELL
$97.2 - $137.59 $1.74 Million - $2.46 Million
-17,900 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$110.06 - $133.7 $44,024 - $53,479
-400 Reduced 2.19%
17,900 $1.99 Million
Q3 2020

Nov 05, 2020

BUY
$99.78 - $124.21 $59,868 - $74,526
600 Added 3.39%
18,300 $2.17 Million
Q2 2020

Aug 12, 2020

BUY
$60.13 - $125.71 $84,182 - $175,994
1,400 Added 8.59%
17,700 $2.01 Million
Q1 2020

May 12, 2020

SELL
$66.76 - $93.49 $13,352 - $18,698
-200 Reduced 1.21%
16,300 $1.09 Million
Q4 2019

Jan 27, 2020

BUY
$84.28 - $118.5 $210,700 - $296,250
2,500 Added 17.86%
16,500 $1.5 Million
Q3 2019

Oct 31, 2019

BUY
$84.4 - $106.53 $655,112 - $826,885
7,762 Added 124.43%
14,000 $1.21 Million
Q2 2019

Aug 15, 2019

BUY
$91.13 - $142.5 $72,904 - $114,000
800 Added 14.71%
6,238 $654,000
Q1 2019

May 03, 2019

SELL
$103.48 - $143.84 $10,348 - $14,384
-100 Reduced 1.81%
5,438 $681,000
Q4 2018

Feb 08, 2019

SELL
$94.77 - $215.54 $490,908 - $1.12 Million
-5,180 Reduced 48.33%
5,538 $624,000
Q3 2018

Nov 13, 2018

BUY
$207.3 - $300.31 $997,113 - $1.44 Million
4,810 Added 81.42%
10,718 $2.3 Million
Q2 2018

Aug 15, 2018

BUY
$101.55 - $313.9 $207,162 - $640,356
2,040 Added 52.74%
5,908 $1.65 Million
Q1 2018

May 11, 2018

BUY
$93.35 - $149.04 $361,077 - $576,486
3,868 New
3,868 $452,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.32B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.